Anti-anginal class drugs

4 results
  • ranolazine

    (Ranolazine)
    Zydus Lifesciences Limited
    Ranolazine extended-release tablets are indicated for the treatment of chronic angina and can be used alongside various medications, including beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering agents, ACE inhibitors, and angiotensin receptor blockers.
  • ranolazine

    (RANOLAZINE)
    AvKARE
    Ranolazine extended-release tablets are indicated for the treatment of chronic angina and may be used in combination with various cardiovascular medications, including beta-blockers, nitrates, and ACE inhibitors.
  • ranolazine

    (Ranolazine)
    Ajanta Pharma USA Inc.
    Ranolazine extended-release tablets are indicated for the treatment of chronic angina and can be used in conjunction with various medications, including beta-blockers, nitrates, and other cardiovascular therapies.
  • ranolazine

    (Ranolazine)
    Viona Pharmaceuticals Inc
    Ranolazine extended-release tablets are indicated for the treatment of chronic angina and can be used alongside various other therapies, including beta-blockers, nitrates, and lipid-lowering agents.